Gravitas: Biocon executives charged with bribing regulators
Indian pharma giant Biocon has been accused of bribing regulators to speed up the approval of their insulin product. How will these changes affect Indian pharma's global brand? Palki Sharma tells you.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)